Advertisement
Advertisement
RDY
Dr. Reddy's Laboratories Limited - ADR
14.07
USDSponsored
+0.01
+0.08%
Dec 31, 14:08 UTC -5
Open
RDY Earnings Reports
Positive Surprise Ratio
RDY beat 22 of 39 last estimates.
56%
Next Report
Date of Next Report
Jan 21, 2026
Estimate for Q3 26 (Revenue/ EPS)
$86.68B
/$14.39
Implied change from Q2 26 (Revenue/ EPS)
-1.81%
/-11.01%
Implied change from Q3 25 (Revenue/ EPS)
+3.42%
/-15.05%
Dr. Reddy's Laboratories Limited - ADR earnings per share and revenue
On Oct 24, 2025, RDY reported earnings of 16.17 USD per share (EPS) for Q2 26, missing the estimate of 17.67 USD, resulting in a -8.52% surprise. Revenue reached 88.28 billion, compared to an expected 89.63 billion, with a -1.51% difference. The market reacted with a -0.75% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 8 analysts forecast an EPS of 14.39 USD, with revenue projected to reach 86.68 billion USD, implying an decrease of -11.01% EPS, and decrease of -1.81% in Revenue from the last quarter.
FAQ
What were Dr. Reddy's Laboratories Limited - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Dr. Reddy's Laboratories Limited - ADR reported EPS of $16.17, missing estimates by -8.52%, and revenue of $88.28B, -1.51% below expectations.
How did the market react to Dr. Reddy's Laboratories Limited - ADR's Q2 2026 earnings?
The stock price moved down -0.75%, changed from $14.58 before the earnings release to $14.47 the day after.
When is Dr. Reddy's Laboratories Limited - ADR expected to report next?
The next earning report is scheduled for Jan 21, 2026.
What are the forecasts for Dr. Reddy's Laboratories Limited - ADR's next earnings report?
Based on 8
analysts, Dr. Reddy's Laboratories Limited - ADR is expected to report EPS of $14.39 and revenue of $86.68B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement